Cargando…

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients

Background: In clinical practice, assessment of the striatal accumulation in (123)I-ioflupane single photon emission computed tomography (SPECT) is commonly performed calculating the specific binding ratio (SBR) for the whole striatum. On the other hand, visual assessment of striatal accumulation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Hidetomo, Kimura, Atsushi, Yasumoto, Taro, Miki, Ayako, Yamamoto, Ken, Ito, Naohito, Momma, Yutaro, Owan, Yoshiyuki, Yano, Satoshi, Ono, Kenjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306624/
https://www.ncbi.nlm.nih.gov/pubmed/30618718
http://dx.doi.org/10.3389/fnagi.2018.00412
_version_ 1783382824561147904
author Murakami, Hidetomo
Kimura, Atsushi
Yasumoto, Taro
Miki, Ayako
Yamamoto, Ken
Ito, Naohito
Momma, Yutaro
Owan, Yoshiyuki
Yano, Satoshi
Ono, Kenjiro
author_facet Murakami, Hidetomo
Kimura, Atsushi
Yasumoto, Taro
Miki, Ayako
Yamamoto, Ken
Ito, Naohito
Momma, Yutaro
Owan, Yoshiyuki
Yano, Satoshi
Ono, Kenjiro
author_sort Murakami, Hidetomo
collection PubMed
description Background: In clinical practice, assessment of the striatal accumulation in (123)I-ioflupane single photon emission computed tomography (SPECT) is commonly performed calculating the specific binding ratio (SBR) for the whole striatum. On the other hand, visual assessment of striatal accumulation in the SPECT was recently established. However, correlations of visual assessment with motor and cognitive functions in Parkinson’s disease (PD) have rarely been examined. Differences in the usefulness of these assessments at clinics are uncertain. Objective: We performed this study to compare correlations of cognitive and motor functions in drug-naive PD between the SBR and visual assessment using (123)I-ioflupane SPECT. Methods: Cognitive and motor assessments and (123)I-ioflupane SPECT were performed in 47 drug-naïve PD patients with Mini-mental State Examination scores of ≥25. Cognitive function was assessed using the total score and 6 subscores of the Montreal Cognitive Assessment (MoCA) and 10 separate subtests of the Neurobehavioral Cognitive Status Examination (COGNISTAT). Motor function was assessed using the Hoehn and Yahr scale and Unified Parkinson’s Disease Rating Scale. Accumulation of (123)I-ioflupane was determined by visual assessment based on five grades: 1, burst striatum; 2, egg-shaped; 3, mixed type; 4, eagle wing; 5, normal striatum; and by calculating SBR averaged for the bilateral striatum using the DaTView computer software commonly used in clinical practice. Each SPECT assessment was compared with each subscore for cognitive and motor assessments. Results: Spearman correlation analysis showed SBR was significantly correlated with the MoCA subscores of visuospatial function and attention, and with COGNISTAT subtests of attention. Visual assessment showed significant negative correlation with the Hoehn and Yahr scale. Mean score of postural instability in patients with visual grade of 1 was significantly higher than those in patients with visual grades of 2 and 3. Conclusion: Clinical symptoms reflected by (123)I-ioflupane SPECT differ between the SBR and visual assessment. SBR reflects some cognitive functions, whereas a visual assessment grade of 1, which signifies decreased uptake of (123)I-Ioflupane in the caudate nucleus, reflects postural instability. Thus, the caudate nucleus may play an important role in posture maintenance. Our results suggest that performing both assessments is of value.
format Online
Article
Text
id pubmed-6306624
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63066242019-01-07 Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients Murakami, Hidetomo Kimura, Atsushi Yasumoto, Taro Miki, Ayako Yamamoto, Ken Ito, Naohito Momma, Yutaro Owan, Yoshiyuki Yano, Satoshi Ono, Kenjiro Front Aging Neurosci Neuroscience Background: In clinical practice, assessment of the striatal accumulation in (123)I-ioflupane single photon emission computed tomography (SPECT) is commonly performed calculating the specific binding ratio (SBR) for the whole striatum. On the other hand, visual assessment of striatal accumulation in the SPECT was recently established. However, correlations of visual assessment with motor and cognitive functions in Parkinson’s disease (PD) have rarely been examined. Differences in the usefulness of these assessments at clinics are uncertain. Objective: We performed this study to compare correlations of cognitive and motor functions in drug-naive PD between the SBR and visual assessment using (123)I-ioflupane SPECT. Methods: Cognitive and motor assessments and (123)I-ioflupane SPECT were performed in 47 drug-naïve PD patients with Mini-mental State Examination scores of ≥25. Cognitive function was assessed using the total score and 6 subscores of the Montreal Cognitive Assessment (MoCA) and 10 separate subtests of the Neurobehavioral Cognitive Status Examination (COGNISTAT). Motor function was assessed using the Hoehn and Yahr scale and Unified Parkinson’s Disease Rating Scale. Accumulation of (123)I-ioflupane was determined by visual assessment based on five grades: 1, burst striatum; 2, egg-shaped; 3, mixed type; 4, eagle wing; 5, normal striatum; and by calculating SBR averaged for the bilateral striatum using the DaTView computer software commonly used in clinical practice. Each SPECT assessment was compared with each subscore for cognitive and motor assessments. Results: Spearman correlation analysis showed SBR was significantly correlated with the MoCA subscores of visuospatial function and attention, and with COGNISTAT subtests of attention. Visual assessment showed significant negative correlation with the Hoehn and Yahr scale. Mean score of postural instability in patients with visual grade of 1 was significantly higher than those in patients with visual grades of 2 and 3. Conclusion: Clinical symptoms reflected by (123)I-ioflupane SPECT differ between the SBR and visual assessment. SBR reflects some cognitive functions, whereas a visual assessment grade of 1, which signifies decreased uptake of (123)I-Ioflupane in the caudate nucleus, reflects postural instability. Thus, the caudate nucleus may play an important role in posture maintenance. Our results suggest that performing both assessments is of value. Frontiers Media S.A. 2018-12-20 /pmc/articles/PMC6306624/ /pubmed/30618718 http://dx.doi.org/10.3389/fnagi.2018.00412 Text en Copyright © 2018 Murakami, Kimura, Yasumoto, Miki, Yamamoto, Ito, Momma, Owan, Yano and Ono. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Murakami, Hidetomo
Kimura, Atsushi
Yasumoto, Taro
Miki, Ayako
Yamamoto, Ken
Ito, Naohito
Momma, Yutaro
Owan, Yoshiyuki
Yano, Satoshi
Ono, Kenjiro
Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title_full Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title_fullStr Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title_full_unstemmed Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title_short Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients
title_sort usefulness differs between the visual assessment and specific binding ratio of (123)i-ioflupane spect in assessing clinical symptoms of drug-naïve parkinson’s disease patients
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306624/
https://www.ncbi.nlm.nih.gov/pubmed/30618718
http://dx.doi.org/10.3389/fnagi.2018.00412
work_keys_str_mv AT murakamihidetomo usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT kimuraatsushi usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT yasumototaro usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT mikiayako usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT yamamotoken usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT itonaohito usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT mommayutaro usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT owanyoshiyuki usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT yanosatoshi usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients
AT onokenjiro usefulnessdiffersbetweenthevisualassessmentandspecificbindingratioof123iioflupanespectinassessingclinicalsymptomsofdrugnaiveparkinsonsdiseasepatients